aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
CellChorus: AI-driven platform for rapid cell therapy & vaccine development analysis.
Founded with the mission to revolutionize cell therapy and vaccine development, CellChorus leverages artificial intelligence to analyze thousands of microscopy videos in parallel. This innovative approach enables the evaluation of immune cell behavior over time, helping customers discover, develop, manufacture, and deliver therapies more efficiently and cost-effectively. Their core product, the TIMING™ platform, quantifies the spatiotemporal performance of individual cells, providing critical insights for top biopharma companies and emerging biotech firms.
Notable figures affiliated with CellChorus include leading scientists and industry experts who contribute to the company's cutting-edge research and development. The company has secured investments from prominent venture capital firms and has achieved significant milestones in accelerating therapeutic development. By enabling a deeper understanding of immune cell performance, CellChorus has made a substantial impact on the biopharma industry, enhancing the success rates of novel therapies and reducing time-to-market.
Operating Status
Active
Ownership Type(s)
Venture Capital, Private Equity
Main Product(s)
Cell Therapy, Vaccines
Technology
AI, Machine Learning
Tags
Biotech, SaaS
Model Types
Platform, Software
Revenue Type(s)
Recurring
Customer Type(s)
Enterprise
Geographic Exposure
Global
When was CellChorus founded?
CellChorus was founded in 2017.
Where is CellChorus’s headquarters located?
CellChorus’s headquarters is located in San Carlos, CA, US.
When was CellChorus’s last funding round?
CellChorus’s most recent funding round was for $2.3M (USD) in June 2023.
How many employees does CellChorus have?
CellChorus has 6 employees as of Feb 5, 2024.
How much has CellChorus raised to-date?
As of July 05, 2023, CellChorus has raised a total of $2.3M (USD) since Jun 21, 2023.
Add Comparison
Total Raised to Date
$2.3M
USD
Last Update Jun 21, 2023
Last Deal Details
$2.3M
USD
Jun 21, 2023
Grant
Total Employees Over Time
6
As of Feb 2024
CellChorus Address
San Carlos,
California
94070
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts